Investment Rating - The report maintains a "Buy" rating for the company with a target price of 29.10 CNY per share [3]. Core Insights - The privatization plan for Yuefeng is expected to significantly increase capacity and cash flow, potentially doubling them. The acquisition price is approximately 40.2 billion CNY, with additional bank loans of up to 61 billion CNY, totaling around 111 billion HKD for 92.77% of Yuefeng's shares. Post-transaction, the company is projected to hold 52% of Yuefeng, leading to an estimated profit increase of 310 million CNY, representing a 22% elasticity based on the 2023 net profit [1][11]. - The company has a history of steady growth, with past acquisitions leading to a market cap exceeding 18 billion CNY. From 2015 to 2021, the company maintained a growth rate of around 30%, aligning with a PE ratio of 20x to 25x. Recent performance has stabilized, with improved cash flow and new growth expectations from the acquisition [1]. - The integration of solid waste assets is becoming increasingly valuable, with the company and Yuefeng being key players in Guangdong's solid waste sector. Their overlapping project areas allow for operational synergies, enhancing their competitive edge and potential for dividend increases [1]. - Profit forecasts for the company from 2024 to 2026 are projected at 1.685 billion CNY, 1.720 billion CNY, and 1.825 billion CNY, respectively, with corresponding PE ratios of 10.15, 9.95, and 9.38 [2]. Summary by Sections Section 1: Privatization of Yuefeng - The company announced a privatization plan for Yuefeng, with a total transaction value of approximately 110.9 to 111.0 billion HKD. The plan involves acquiring 92.8% of Yuefeng's shares, with the company expected to hold 52% post-transaction [11][12]. Section 2: Yuefeng's Financial Stability - Yuefeng has a total operational capacity of 43,700 tons per day, with half located in Guangdong. The company reported a net profit of 900 million CNY in 2023, with a significant portion of its revenue coming from waste-to-energy projects [17][20]. Section 3: Capacity and Profitability Projections - The company anticipates a near doubling of capacity and cash flow post-acquisition, with a projected stable profit of 1.8 billion CNY by 2026 if the privatization is successful. The current market PE for the solid waste industry averages 13x, indicating a potential upside of 39% to 62% for the company's market valuation [1][2]. Section 4: Financial Forecasts - Revenue forecasts for the company are set at 12.875 billion CNY for 2022, with a slight decline to 12.541 billion CNY in 2023, followed by a recovery to 13.153 billion CNY in 2024. The expected growth rates for the following years are 4.9%, 3.4%, and 4.1% [2].

[Table_Page] 跟踪分析|生物制品 证券研究报告 [Table_Title] 生物制品行业 2024 年 1-6 月生物制品批签发跟踪 [Table_Summary] 核心观点： ⚫ 血制品行业批签发概况：2024 年 1-6 月白蛋白、Ⅷ因子同比有所增长， 静丙、纤原、PCC 同比略有下降。（1）人血白蛋白：2024 年 1-6 月 我国人血白蛋白批签发合计 2925 批次，同比保持稳健增长，进口白蛋 白批签发次数占比保持在 70%。（2）静丙：2024 年 1-6 月我国静注人 免疫球蛋白批签发合计 666 批次，同比略有下降，主要受 23 年同期高 基数影响。（3）凝血因子 VIII：2024 年 1-6 月我国人凝血因子Ⅷ批签 发合计 307 批次，同比有所增长，派林生物、上海莱士增幅领先。（4） 人凝血酶原复合物： 2024 年 1-6 月我国人凝血酶原复合物批签发合 计 143 批次，同比略有下滑。（5）人纤维蛋白原：2024 年 1-6 月我国 人纤维蛋白原批签发合计 129 批次，同比略有下滑，博雅生物、上海 莱士保持领先。（数据来源：中检院及各地方检院） ⚫ 疫苗行业批签发概况：2 ...

[Table_Page] 投资策略周报|机械设备 证券研究报告 [Table_Title] 机械设备行业 设备更新政策与降息落地，提振稳定型资产投资 [Table_Summary] 核心观点： ⚫ 2024 年 7 月 22 日，新一期贷款市场报价利率（LPR）发布，1 年期 和 5 年期以上 LPR 双双下降 10 个基点。这是 LPR 年内第二次下降， 将进一步降低企业、居民融资成本，有望提振消费和投资。7 月 25 日 国家发展改革委和财政部印发了《关于加力支持大规模设备更新和消 费品以旧换新的若干措施》，并统筹安排 3000 亿元左右超长期特别国 债资金用于支持。《若干措施》系对此前文件的落实，提及要支持范围 扩大到能源电力、老旧电梯等领域设备更新以及重点行业节能降碳和 安全改造，并新增或者提高了船舶、货车、农业机械、新能源公交车及 动力电池 4 个行业的老旧设备报废更新补贴。 ⚫ 市场表现分析：上周（7 月 29 日-8 月 2 日）机械行业指数（中信）下 跌 1.75%，沪深 300 指数上涨 0.31%，创业板指上涨 0.01%。 ⚫ 机械动态变化：根据克拉克森，截至 8 月 3 日，今年以来全 ...

[Table_Page] 行业专题研究|传媒 2024 年 8 月 6 日 证券研究报告 [Table_Title] 传媒行业 微软 AI 业务概览：以 Azure 为核心构建生态，围绕企业端推动业务落地 | --- | --- | --- | --- | |----------------|----------------------------|----------|----------------------------| | 分析师： [Tabl | 旷实 | 分析师： | 章驰 | | e_Author] | SAC 执证号：S0260517030002 | | SAC 执证号：S0260523080001 | SFC CE.no: BNV294 010-59136610 021-38003814 kuangshi@gf.com.cn gfzhangc@gf.com.cn 请注意，章驰并非香港证券及期货事务监察委员会的注册持牌人，不可在香港从事受监管活动。 [Table_Summary] 核心观点： ⚫ AI 基础设施：加大资本开支，全球打造基础设施。硅谷巨头在 AI 基础设施的布局明显增加，资本开 ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 57.31 CNY per share, indicating an expected strong performance relative to the market over the next 12 months [3][10]. Core Insights - In July, the company's pig sales volume increased by 21.5% month-on-month, with a total of 6.158 million pigs sold, resulting in a sales revenue of 13.405 billion CNY, a year-on-year increase of 43.5%. The increase in sales is attributed to prior growth in breeding stock and improved production efficiency [1][2]. - The company is focused on high-quality development, with a steady increase in the breeding stock. As of the end of June, the breeding sow inventory was 3.309 million, up by approximately 110,000 from April, supporting stable sales growth [1][2]. - Profitability is expected to exceed expectations due to rising pig prices and declining costs. The report notes that the recent increase in pig prices is likely to continue as the consumption peak approaches, benefiting from a widening gap between rising prices and falling costs [1][2]. - Earnings per share (EPS) forecasts for 2024-2026 are projected at 3.19, 3.98, and 4.97 CNY, respectively, with a maintained reasonable value of 57.31 CNY per share, corresponding to a PE ratio of 18 times for 2024 [1][2]. Financial Summary - The company's revenue for 2022 was 124.826 billion CNY, with a projected revenue of 137.033 billion CNY for 2024, reflecting a growth rate of 23.6% [2]. - The EBITDA for 2022 was 29.848 billion CNY, with an expected increase to 36.705 billion CNY in 2024 [2]. - The net profit attributable to the parent company was 13.266 billion CNY in 2022, with a forecasted recovery to 17.416 billion CNY in 2024, indicating a significant growth rate of 508.5% [2].

[Table_Title] 房地产行业 2024 年 6 月公司月报 央企销售率先修复，信用债成本再创新低 [Table_Summary] 核心观点： ⚫ 房企销售：市场筑底修复，央企实现增长。根据公司销售公告及克而 瑞数据，24 年 6 月百强房企实现销售金额 4702 亿元，同比下降 21.8%， 降幅环比收窄 13.6pct；6 月重点跟踪房企实现销售金额 3148 亿元， 同比下降 16.3%，降幅环比收窄 18.7pct，受政策转向影响，市场销售 降幅已连续 5 月持续收窄。6 月央企销售金额同比增长 8.4%，由负转 正，地方国企、民企销售同比下降 28.3%、45.3%。具体来看，中海、 滨江、华润等 7 家单月销售金额同比增长，中海增长超 40%，华润、 滨江增长约 20%，年内销售表现前五的房企中除绿城为混合所有制外 其余均为央国企，行业信用下跌时期央国企经营表现明显优于民企。 ⚫ 房企拿地：拿地维持低位，利润达到新高。根据公司拿地公告、克而 瑞及中指院数据，24 年 6 月 44 家样本房企中拿地规模同比下降 84%， 环比增长 23%，处于历史较低分位。6 月 44 家样本房企合计拿地力 ...

[Table_Title] 医药生物行业 建议关注院内诊疗相关资产修复 [Table_Summary] 核心观点： ⚫ 过去一年国家开展了系统性医疗反腐工作，对医疗行为进行规范，为未 来真正具备临床价值的诊疗行为提供了更广阔和健康的发展空间。在 工作执行的过程中，医疗机构的诊疗活动、上游产品（药/械）出现一 定波动。随着行业的规范化，我们认为医疗板块将逐步回到健康的成长 轨道上。 ⚫ 7 月申万医药指数上涨 0.22%，涨幅在全行业排名居中。截至 2024 年 7 月 31 日，申万医药生物指数 PE（TTM，剔除负值）为 24x，相对沪 深 300 估值溢价率 212.7%（均值为 296.8%），仍处于底部区间，板 块配置性价比较高。 ⚫ 子版块中医疗服务 7 月领涨。7 月医药生物行业（申万）的二级子板块 中，涨幅最高的是医疗服务，上涨 6.31%，跑赢沪深 300 指数 6.88 个 百分点，跑赢医药生物指数 6.09 个百分点。化学制药板块涨幅排名第 二，7 月上涨 2.23%。跌幅最高的为医疗器械板块，7 月下跌 3.40%。 ⚫ 投资建议。1. 制药和 Biotech 建议关注：恒瑞医药、人福医 ...

[Table_Page] 行业专题研究|软件与服务 2024 年 8 月 6 日 证券研究报告 [Table_Title] 软件与服务行业 微软、Meta 收入达指引上限，延续高资本开支，微软 Azure 略低于预期 [Tabl e_Author] 分析师： 杨琳琳 SAC 执证号：S0260514050004 SFC CE.no: BNC117 0755-23480370 yll@gf.com.cn [Table_Summary] 核心观点：（备注：本文如无特别说明，数据来源均为公司财报、Earnings Call 记录及演示材料、官网等官方公开信息） ⚫ 微软：业绩延续增长，Azure 低于预期，维持资本开支季比增长。FY24Q4 业绩略高于指引上限，根据财报， FY24Q4 收入同比+15.2%，净利润同比+9.7%，剔除会计估算影响后毛利率利润率略增。下季度收入指引略放 缓，根据 FY24Q4 Earnings Call，公司指引 FY25Q1 收入同比+12.9%~14.7%；FY2025 收入和运营利润实现 两位数增长，维持运营利润率同比-1pct。资本开支维持季比增长，FY24Q4 为 190 ...

Investment Rating - The report assigns a "Buy" rating for the food and beverage industry [1][3]. Core Insights - The report emphasizes the transition to a low-growth era for the food and beverage industry, highlighting the importance of identifying growth potential, market pricing, and capital allocation strategies in this new normal [1][8]. - Domestic demand remains resilient, with opportunities for explosive products still anticipated, despite challenges in the macroeconomic environment [1][9]. - The report discusses the significance of efficiency and structural optimization in profit generation, suggesting that companies should focus on cost reduction and enhancing operational efficiency [1][9]. Summary by Sections 1. Introduction: Embracing the Low-Growth Era - The food and beverage industry is entering a low-growth phase, prompting companies to seek growth potential and adapt to changing market conditions [1][8]. 2. Revenue: Resilience in Domestic Demand - Domestic demand is expected to remain robust, with explosive products likely to emerge from generational changes in consumer preferences [1][9]. - The report notes that the growth rate of domestic demand is closely aligned with nominal GDP growth [1][9]. 3. Profit: Focusing on Efficiency - Companies are encouraged to adopt efficiency as a key strategy, seeking profit through both internationalization and diversification [1][9]. - The report highlights the importance of cost reduction and efficiency improvements in maintaining profitability amid macroeconomic fluctuations [1][9]. 4. Pricing: From PEG to PB-ROE - The report discusses the transition from PEG to PB-ROE as a pricing framework, emphasizing that low growth does not equate to low returns [1][9]. - It suggests that companies can achieve stable returns through consistent dividend policies, even in a low-growth environment [1][9]. 5. Investment Recommendations - The report recommends specific companies for investment, including Guizhou Moutai, Wuliangye, Luzhou Laojiao, Mengniu Dairy, Yanjing Beer, Qianhe Flavor, Qianwei Central Kitchen, and Dongpeng Beverage, based on their growth potential and market positioning [1][2][3].

Xml [Table_Title] 国防军工行业 优选"供需"与"格局"稀缺性共振的龙头白马 [Table_Summary] 核心观点： ⚫ 全球商业航空、船舶景气度持续，国内企业有望领先受益。美国锻件 公司豪梅特是全球领先飞机结构件供应商，24 年第二季度营收同比增 长 14%，其中商业航空为主要增长点，同比增长 27%，并提高全年业 绩指引。据中国船舶工业行业协会，我国船舶企业上半年经营取得良 好业绩，进入下半年，多家船舶企业顺利签订一批新船订单。 ⚫ 商业航天、低空经济加速发展，政策落地、卫星互联网建设有望实现 实质性突破。商业航天方面，据上海经信委公众号，火箭端长征十二 号运载火箭有望在八月执行首飞。据中国航天报，本月初长三乙火箭 成功发射卫星互联网高轨卫星 02 星；据我们的太空公众号，"千帆星 座"首批组网卫星发射仪式将于 8 月 5 日在太原举行，届时格思航天 将完成"一箭 18 星"发射。低空经济方面，深圳发改委发布《深圳市 低空起降设施高质量建设方案（2024-2025）》，未来深圳将构建层次 分明、结构合理的低空起降服务体系，计划到 2025 年底，建成 1000 个以上低空飞行器起降平台 ...